Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Inhaled ciclosporin added to immunosuppression beneficial in lung transplant patients

Jan. 18, 2006

Enrollment open in phase IIb kidney transplant study of ISA-247

Jan. 13, 2006

FDA approval for subcutaneous immunoglobulin treatment Vivaglobin

Jan. 11, 2006

Immunosuppressive effects of NK-026680 useful for acute GVHD

Jan. 5, 2006

IDM Pharma completes sale of non-core assets to Pharmexa

Jan. 5, 2006

Pharming files for GRAS notification for human lactoferrin

Jan. 3, 2006

Astellas submits NDA for FK-506 modified release formulation

Dec. 28, 2005

FTC clearance for Roche's licensing of BCX-4208

Dec. 27, 2005

Tanabe Seiyaku launches Mearubik combined vaccine for measles and rubella

Dec. 23, 2005

Orphan drug designation for Prochymal in GVHD

Dec. 23, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...